Showing results (1-10 of 49) with videos related to
Sort By:
Pageof 5
Diagnostic Microbiology and Infectious Disease|November 1, 1992
Susceptibility testing interpretive criteria and drug stability for cefdinir, cefetamet, and cefpodoxime against Neisseria gonorrhoeaeM S Barrett, R N JonesDiagnostic Microbiology and Infectious Disease|July 1, 1996
In vitro activity of quinupristin/dalfopristin (RP 59500) against a large collection of infrequently isolated or tested speciesM S Barrett, R N JonesDiagnostic Microbiology and Infectious Disease|February 1, 1996
Antimicrobial activity and spectrum of sparfloxacin tested against erythromycin-resistant Streptococcus pneumoniae isolatesM S Barrett, R N JonesEuropean Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|May 1, 1992
Interpretive criteria for CI-960, fleroxacin and temafloxacin susceptibility tests with Haemophilus influenzaeM S Barrett, R N JonesEuropean Journal of Applied Physiology|April 29, 2025
Prolonged running reduces speed at the moderate-to-heavy intensity transition without additional reductions due to increased eccentric loadAndrew M S Barrett, Ed MaunderJournal of Consulting and Clinical Psychology|September 12, 2001
Is psychotherapy more effective when therapists disclose information about themselves?M S Barrett, J S BermanDiagnostic Microbiology and Infectious Disease|April 29, 1998
Timed kill kinetic studies of levofloxacin, ofloxacin, and ciprofloxacin against Moraxella catarrhalisM S Barrett, R N JonesDiagnostic Microbiology and Infectious Disease|April 1, 1997
Antimicrobial characteristics of quinupristin/dalfopristin (Synercid at 30:70 ratio) compared to alternative ratios for in vitro testingC Jamjian, M S Barrett, R N JonesArchives of Surgery (Chicago, Ill. : 1960)|July 1, 1985
In situ femoropopliteal and infrapopliteal bypass. Two-year experienceW I Carney, A Balko, M S BarrettDiagnostic Microbiology and Infectious Disease|August 1, 1997
Antimicrobial activity of trovafloxacin tested against ciprofloxacin-susceptible and -resistant Neisseria gonorrhoeae. Interpretive criteria and comparisons with Etest resultsR N Jones, M S Barrett, T DeguchiPageof 5